Hasegawa S - Search Results

1

Mild elevation of urinary biomarkers in prerenal acute kidney injury.

Doi K, Katagiri D, Negishi K, Hasegawa S, Hamasaki Y, Fujita T, Matsubara T, Ishii T, Yahagi N, Sugaya T, Noiri E. Doi K, et al. Among authors: hasegawa s. Kidney Int. 2012 Nov;82(10):1114-20. doi: 10.1038/ki.2012.266. Epub 2012 Aug 1. Kidney Int. 2012. PMID: 22854644 Free article.

2

Positron emission tomography in the diagnosis of cyst infections.

Hasegawa S, Kato H, Hamasaki Y, Koiwa T, Nangaku M. Hasegawa S, et al. Kidney Int. 2017 Mar;91(3):759. doi: 10.1016/j.kint.2016.10.025. Kidney Int. 2017. PMID: 28202176 Free article. No abstract available.

3

Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury.

Saito H, Tanaka T, Tanaka S, Higashijima Y, Yamaguchi J, Sugahara M, Ito M, Uchida L, Hasegawa S, Wakashima T, Fukui K, Nangaku M. Saito H, et al. Among authors: hasegawa s. Physiol Rep. 2018 May;6(10):e13707. doi: 10.14814/phy2.13707. Physiol Rep. 2018. PMID: 29845768 Free PMC article.

4

Comprehensive three-dimensional analysis (CUBIC-kidney) visualizes abnormal renal sympathetic nerves after ischemia/reperfusion injury.

Hasegawa S, Susaki EA, Tanaka T, Komaba H, Wada T, Fukagawa M, Ueda HR, Nangaku M. Hasegawa S, et al. Kidney Int. 2019 Jul;96(1):129-138. doi: 10.1016/j.kint.2019.02.011. Epub 2019 Apr 9. Kidney Int. 2019. PMID: 30979565 Free article.

5

The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease.

Hasegawa S, Tanaka T, Saito T, Fukui K, Wakashima T, Susaki EA, Ueda HR, Nangaku M. Hasegawa S, et al. Kidney Int. 2020 May;97(5):934-950. doi: 10.1016/j.kint.2019.12.007. Epub 2019 Dec 25. Kidney Int. 2020. PMID: 32171449 Free article.

6

Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease.

Yoshioka K, Hirakawa Y, Kurano M, Ube Y, Ono Y, Kojima K, Iwama T, Kano K, Hasegawa S, Inoue T, Shimada T, Aoki J, Yatomi Y, Nangaku M, Inagi R. Yoshioka K, et al. Among authors: hasegawa s. Kidney Int. 2022 Mar;101(3):510-526. doi: 10.1016/j.kint.2021.10.039. Epub 2021 Nov 29. Kidney Int. 2022. PMID: 34856312 Free article.

7

SGLT2 inhibition in chronic kidney disease: a preventive strategy against acute kidney injury at the same time?

Hasegawa S, Nangaku M. Hasegawa S, et al. Kidney Int. 2022 Jan;101(1):20-22. doi: 10.1016/j.kint.2021.10.013. Kidney Int. 2022. PMID: 34991813

8

Anti-aging mechanism of calorie restriction in humans.

Hasegawa S, Nangaku M. Hasegawa S, et al. Kidney Int. 2022 Aug;102(2):223-225. doi: 10.1016/j.kint.2022.03.016. Epub 2022 Apr 2. Kidney Int. 2022. PMID: 35378145 No abstract available.

9

Urinary single-cell transcriptomics: a promising noninvasive method for assessing acute kidney injury.

Hasegawa S. Hasegawa S. Kidney Int. 2022 Dec;102(6):1219-1221. doi: 10.1016/j.kint.2022.09.006. Kidney Int. 2022. PMID: 36411018

10

Neuroimmune interactions and kidney disease.

Hasegawa S, Inoue T, Inagi R. Hasegawa S, et al. Kidney Res Clin Pract. 2019 Sep 30;38(3):282-294. doi: 10.23876/j.krcp.19.014. Kidney Res Clin Pract. 2019. PMID: 31422643 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,095 results

Search Page

Filters